Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Journal Article
Athyros, V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2010).  Statin-fibrate combination for mixed dyslipidaemia: a limited option?. Curr Med Res Opin. 26(9), 2137-40.
Athyros, V. G., & Wierzbicki A. S. (2014).  Statin-fibrate combination therapy is safe and effective in normalizing lipid profile and in keeping cardiovascular event rates low.. Curr Med Res Opin. 30(1), 57-8.
Athyros, V. G., Kakafika A. I., Papageorgiou A. A., Pagourelias E. D., Savvatianos S. D., Elisaf M., et al. (2007).  Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients.. Open Cardiovasc Med J. 1, 8-14.
Athyros, V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. (2009).  Statins and cardiovascular events in patients with end-stage renal disease on hemodialysis. The AURORA results suggest the need for earlier intervention.. Curr Vasc Pharmacol. 7(3), 264-6.
Athyros, V. G., Karagiannis A., & Mikhailidis D. P. (2010).  Statins and heart failure.. J Am Coll Cardiol. 55(15), 1644-5; author reply 1646.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2013).  Statins and nonalcoholic fatty liver disease: a bright future?. Expert Opin Investig Drugs. 22(9), 1089-93.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2016).  Statins and non-alcoholic steatohepatitis.. J Hepatol. 64(1), 241-2.
Athyros, V. G., Kakafika A., Karagiannis A., & Mikhailidis D. P. (2007).  Statins and regression of coronary atherosclerosis.. JAMA. 297(20), 2197; author reply 2197.
Athyros, V. G., Karagiannis A., Kakafika A., Elisaf M., & Mikhailidis D. P. (2007).  Statins and renal function. Is the compound and dose making a difference?. Nephrol Dial Transplant. 22(3), 963-4; author reply 964.
Katsiki, N., Athyros V. G., Karagiannis A., & Mikhailidis D. P. (2016).  Statins and Type 2 Diabetes Mellitus: An Update After 1 Year.. Curr Pharm Des. 22(18), 2723-5.
Tsartsalis, A. N., Dokos C., Kaiafa G. D., Tsartsalis D. N., Kattamis A., Hatzitolios A. I., et al. (2012).  Statins, bone formation and osteoporosis: hope or hype?. Hormones (Athens). 11(2), 126-39.
Athyros, V. G., Katsiki N., Karagiannis A., & Mikhailidis D. P. (2015).  Statins can improve proteinuria and glomerular filtration rate loss in chronic kidney disease patients, further reducing cardiovascular risk. Fact or fiction?. Expert Opin Pharmacother. 16(10), 1449-61.
Paraskevas, K. I., Athyros V. G., Briana D. D., Kakafika A. I., Karagiannis A., & Mikhailidis D. P. (2007).  Statins exert multiple beneficial effects on patients undergoing percutaneous revascularization procedures.. Curr Drug Targets. 8(8), 942-51.
Athyros, V. G., Kakafika A. I., Tziomalos K., Papageorgiou A. A., & Karagiannis A. (2008).  Statins for the prevention of first or recurrent stroke.. Curr Vasc Pharmacol. 6(2), 124-33.
Koskinas, K. C., & Giannoglou G. D. (2012).  Statins, plaque regression, and arterial remodeling: systemic drug effect, local effect, or a combination thereof?. Am J Cardiol. 110(2), 318.
Paraskevopoulos, E., Chalas N., Kartsidis P., Wollbrink A., & Bamidis P. (2018).  Statistical learning of multisensory regularities is enhanced in musicians: An MEG study.. Neuroimage. 175, 150-160.
Kotoula, V., Lambaki S., Televantou D., Kalogera-Fountzila A., Nikolaou A., Markou K., et al. (2011).  STAT-Related Profiles Are Associated with Patient Response to Targeted Treatments in Locally Advanced SCCHN.. Transl Oncol. 4(1), 47-58.
Spyridi, S., Sokolaki S., Nimatoudis J., Iacovides A., & Kaprinis G. (2009).  Status epilepticus in a patient treated with olanzapine and mirtazapine.. Int J Clin Pharmacol Ther. 47(2), 120-3.
Papavramidou, N., Nasta M., & Karpouzis A. (2010).  Steatoma through the early medical history.. Arch Dermatol. 146(4), 417.
Apalla, Z., Lallas A., Sotiriou E., Lazaridou E., Vakirlis E., & Ioannides D. (2017).  Stellate erosion: the dermoscopic Nikolsky sign?. Eur J Dermatol. 27(6), 659-660.
Gavriilidis, G. I., Ntoufa S., Papakonstantinou N., Kotta K., Koletsa T., Chartomatsidou E., et al. (2020).  Stem cell factor Is implicated In microenvironmental interactions and cellular dynamics of chronic lymphocytic leukemia.. Haematologica.
Siska, E. K., Koliakos G., & Petrakis S. (2015).  Stem cell models of polyglutamine diseases and their use in cell-based therapies.. Front Neurosci. 9, 247.
Tzouvelekis, A., Koliakos G., Ntolios P., Baira I., Bouros E., Oikonomou A., et al. (2011).  Stem cell therapy for idiopathic pulmonary fibrosis: a protocol proposal.. J Transl Med. 9, 182.
Locatelli, F., Bersano A., Ballabio E., Lanfranconi S., Papadimitriou D., Strazzer S., et al. (2009).  Stem cell therapy in stroke.. Cell Mol Life Sci. 66(5), 757-72.
Koliakos, G. (2017).  Stem Cells and Aging.. Rejuvenation Res. 20(1), 4-8.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές